

Novo Nordisk Foundation and the Evolution of Quantum Computing
8 snips Jul 29, 2025
Lene Oddershede, Chief Scientific Officer for Planetary Science & Technology at the Novo Nordisk Foundation, dives into the transformative power of quantum computing. She reveals how advancements in this field could revolutionize healthcare and biotechnology, addressing challenges like achieving fault tolerance in qubits. The conversation also touches on the competitive global landscape in quantum tech, potential breakthroughs in drug discovery, and the pivotal role of artificial intelligence in shaping the future of this emerging technology.
AI Snips
Chapters
Transcript
Episode notes
Quantum Computing Qubit Milestones
- We are currently at a limit where classical computing can simulate about 40 qubits, but advancing to 100 logical qubits will exceed classical capabilities.
- The evolution from superconducting to neutral atoms or trapped ions indicates a new generation of more fault-tolerant quantum computers is near.
Streamline European Quantum Investment
- Europe needs to streamline and unify its quantum computing investments to compete globally.
- Reducing regulatory hurdles and creating a true single market will attract more investors and businesses.
Need for Quantum Killer Use Case
- Quantum computing progress needs a clear "killer use case" to demonstrate undeniable advantage over classical computing.
- Without this standout example, industry adoption and investment may lag significantly.